Breaking News Instant updates and real-time market news.

T

AT&T

$30.41

0.11 (0.36%)

12:26
11/19/18
11/19
12:26
11/19/18
12:26

White House still seeking to take Jim Acosta's press pass away, WSJ says

The White House is still trying to strip CNN reporter Jim Acosta of his press credential, the Wall Street Journal reports. Lawyers for Acosta, CNN's chief White House correspondent, said in a court filing that they had received a letter last week suggesting that the Trump administration was still aiming to strip away his credential following a testy exchange with the president in a news conference earlier this month, the report says. Reference Link

  • 03

    Dec

T AT&T
$30.41

0.11 (0.36%)

11/05/18
UBSW
11/05/18
DOWNGRADE
Target $34
UBSW
Neutral
Viacom downgraded to Neutral on tough AT&T renewal at UBS
As reported previously, UBS analyst John Hodulik downgraded Viacom (VIAB) to Neutral from Buy. The analyst believes the company will face a tough renewal with AT&T (T) in the second half of of 2019. He said Viacom has a low viewership relative to affiliate revenues, a lack of "must have" content, and a lack of carriage on other vMVPDs. Hodulik lowered his price target to $34 from $38 on Viacom shares.
10/22/18
10/22/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Intel (INTC) upgraded to Buy from Neutral at Nomura Instinet with analyst Romit Shah saying he believes Intel is a buy at current share levels. 2. AT&T (T) upgraded to Buy from Neutral at Tigress Financial with analyst Ivan Feinseth saying the upcoming launch of its high-speed 5G wireless communication network and the integration of Time Warner's content "creates a significant investment opportunity." 3. M&T Bank (MTB) upgraded to Overweight from Neutral at Piper Jaffray with analyst Kevin Barker saying this quarter, M&T's deposit base remained steady, its loan/deposit ratio declined and management felt confident the ratio would remain in the 95%-100% range for the foreseeable future. 4. Chipotle (CMG) upgraded to Outperform from Sector Perform at RBC Capital with analyst David Palmer saying while Q3 earnings may be "lackluster," he expects comps to improve from 4% to 6% through the second half of FY19 and raises his FY20 EPS vie to $16.30 from $15.86 on implied 3-turn multiple increase to 31-times forward earnings. 5. SAP (SAP) upgraded to Buy from Neutral at UBS with analyst Michael Briest saying the company deserves credit for sustaining 6%-10% underlying sales growth over the past 12 quarters, with "impressive" cloud growth at scale. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/22/18
TIGR
10/22/18
UPGRADE
TIGR
Buy
AT&T upgraded to Buy from Neutral at Tigress Financial
Tigress Financial analyst Ivan Feinseth upgraded AT&T to Buy saying the upcoming launch of its high-speed 5G wireless communication network and the integration of Time Warner's content "creates a significant investment opportunity." AT&T will "significantly benefit from its merger with Time Warner creating one of the media industry's largest and most dynamic companies," Feinseth tells investors in a research note.
10/18/18
NEED
10/18/18
NO CHANGE
Target $17
NEED
Buy
Adtran price target lowered to $17 at Needham on Q3 revenue slip
Needham analyst Richard Valera nudged his price target on Adtran (ADTN) lower to $17 from $18 and also lowered his FY19 EPS view to 15c from 42c after its Q3 revenues came in "light due to an explainable slip out of shipments to NBN". The analyst also notes the management's more downbeat view of its G.Fast program with AT&T (T), along with a generally more muted outlook for next year. Valera keeps a Buy on Adtran however, stating that although the stock is setting new 52-week lows on a series of disappointments, its valuation multiple of 1.1-times enterprise value to expected 2018 sales is supportive of the rating.

TODAY'S FREE FLY STORIES

EMR

Emerson

$60.45

-0.29 (-0.48%)

05:31
12/17/18
12/17
05:31
12/17/18
05:31
Downgrade
Emerson rating change  »

Emerson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFA

MFA Financial

$6.98

-0.01 (-0.14%)

05:27
12/17/18
12/17
05:27
12/17/18
05:27
Upgrade
MFA Financial rating change  »

MFA Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

05:27
12/17/18
12/17
05:27
12/17/18
05:27
Hot Stocks
Incyte, Innovent announce strategic collaboration, licensing agreement »

Incyte and Innovent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

CSL

Carlisle

$96.53

-1.69 (-1.72%)

05:26
12/17/18
12/17
05:26
12/17/18
05:26
Upgrade
Carlisle rating change  »

Carlisle upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:25
12/17/18
12/17
05:25
12/17/18
05:25
Hot Stocks
Roche SMA treatment risdiplam granted PRIME designation by EMA »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

  • 18

    Mar

SMG

Scotts Miracle-Gro

05:25
12/17/18
12/17
05:25
12/17/18
05:25
Upgrade
Scotts Miracle-Gro rating change  »

Scotts Miracle-Gro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFA

MFA Financial

$6.98

-0.01 (-0.14%)

05:24
12/17/18
12/17
05:24
12/17/18
05:24
Upgrade
MFA Financial rating change  »

MFA Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGI

Triumph Group

$13.23

0.13 (0.99%)

05:18
12/17/18
12/17
05:18
12/17/18
05:18
Upgrade
Triumph Group rating change  »

Triumph Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$82.34

-1.35 (-1.61%)

05:16
12/17/18
12/17
05:16
12/17/18
05:16
Upgrade
LyondellBasell rating change  »

LyondellBasell upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EC

Ecopetrol

$18.36

-0.33 (-1.77%)

, YPF

YPF

$14.38

0.03 (0.21%)

05:11
12/17/18
12/17
05:11
12/17/18
05:11
Recommendations
Ecopetrol, YPF, Petrobras analyst commentary  »

Ecopetrol price target…

EC

Ecopetrol

$18.36

-0.33 (-1.77%)

YPF

YPF

$14.38

0.03 (0.21%)

PBR

Petrobras

$13.40

-0.235 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$62.29

0.96 (1.57%)

05:04
12/17/18
12/17
05:04
12/17/18
05:04
Recommendations
Alaska Air analyst commentary  »

Alaska Air called a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$17.58

-0.14 (-0.79%)

04:59
12/17/18
12/17
04:59
12/17/18
04:59
Initiation
Avaya initiated  »

Avaya initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$102.30

-0.94 (-0.91%)

04:57
12/17/18
12/17
04:57
12/17/18
04:57
Initiation
Argenx initiated  »

Argenx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORTX

Orchard Therapeutics

$15.00

-0.01 (-0.07%)

04:56
12/17/18
12/17
04:56
12/17/18
04:56
Upgrade
Orchard Therapeutics rating change  »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHW

Sherwin-Williams

$385.73

-0.075 (-0.02%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Upgrade
Sherwin-Williams rating change  »

Sherwin-Williams upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHN

Achillion

$3.12

0.035 (1.14%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Achillion to hold a conference call »

Dr. Stephen Zelenkofske,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

MDP

Meredith

$53.26

-0.54 (-1.00%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Meredith management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

EQH

AXA Equitable

$16.87

-0.67 (-3.82%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
AXA Equitable to hold a conference call »

Investor Conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AEYE

AudioEye

$6.99

-0.09 (-1.27%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
AudioEye management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

TLRA

Telaria

$2.81

-0.02 (-0.71%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Telaria management to meet with Lake Street »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

CSCO

Cisco

$45.80

-1.66 (-3.50%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
UBS to host a conference call with Cisco »

UBS IT Hardware Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 10

    Jan

  • 04

    Mar

MGPI

MGP Ingredients

$56.54

0.05 (0.09%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
MGP Ingredients management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call »

Retail/Hardlines Analyst…

EFX

Equifax

$97.19

0.07 (0.07%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Equifax to meet with investors »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

04:55
12/17/18
12/17
04:55
12/17/18
04:55
General news
Housing Market Index to be reported at 10:00 »

December Housing Market…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.